Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Regeneron's arthritis drug nails it in phase III
BioPharma Dive
Fri, 05/22/15 - 10:44 am
Regeneron
Sarilumab
rheumatoid arthritis
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
BioPharma Dive
Thu, 05/21/15 - 08:47 am
Amgen
PCSK9 inhibitor
Repatha
Europe
Sanofi
Regeneron
Praluent
Sanofi/Regeneron reports glowing phase 2b results for versatile asthma hopeful
BioPharma Dive
Wed, 05/20/15 - 06:18 pm
Sanofi
Regeneron
dupilumab
asthma
Regeneron speeds toward the FDA with its would-be asthma blockbuster
Fierce Biotech
Mon, 05/18/15 - 09:56 pm
Regeneron
FDA
asthma
dupilumab
Sanofi
How pharma is amping up R&D with gene sequencing
BioPharma Dive
Fri, 05/15/15 - 09:29 am
R&D
gene sequencing
Regeneron
Pfizer
Genentech
Biogen
Roche
Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development
Seeking Alpha
Mon, 05/11/15 - 08:28 am
Regeneron
earnings
Regeneron profit rises as Eylea sales jump
Yahoo/Reuters
Thu, 05/7/15 - 09:17 am
Regeneron
earnings
Regeneron expects Eylea sales to rise 30-35 pct this year
Yahoo/Reuters
Thu, 05/7/15 - 09:15 am
Regeneron
Eylea
Sanofi/Regeneron eczema drug could have limited competition
Medical Marketing and Media
Wed, 05/6/15 - 06:54 pm
Sanofi
Regeneron
eczema
dupilumab
pSivida, Moore's Law, Pfizer, And The Next Regeneron
Seeking Alpha
Tue, 05/5/15 - 08:44 am
pSivida
Pfizer
Regeneron
More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes
Forbes
Tue, 04/28/15 - 08:45 am
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
Regeneron CEO to join NY Gov. Cuomo on historic Cuba trade trip
BioPharma Dive
Thu, 04/16/15 - 10:07 am
Regeneron
Cuba
Leonard Schleifer
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
FDA again expands usage of Regeneron eye drug Eylea
Yahoo/Reuters
Thu, 03/26/15 - 07:49 am
Eylea
Regeneron
FDA
Opdivo, Praluent and LCZ-696 top a launch crop poised for $27B in sales
Fierce Pharma Marketing
Wed, 03/25/15 - 03:13 pm
drug launches
Opdivo
Bristol-Myers Squibb
Praluent
Sanofi
Regeneron
LCZ696
Novartis
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
Fore! Regeneron CEO Must Pay for his Own Golf Club Membership
WSJ Pharmalot
Fri, 03/20/15 - 08:34 pm
Regeneron
executive pay
Leonard Schleifer
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/20/15 - 01:13 pm
biotech
Gilead Sciences
Amgen
Celgene
Biogen Idec
Regeneron
Alexion
Vertex Pharmaceuticals
Illumina
Biomarin
Agilent
New Cholesterol Meds May Lower Heart Risks, but Will They Break the Bank?
WSJ Pharmalot
Fri, 03/20/15 - 10:58 am
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Amgen, Regeneron Stocks Go Up as Drugs Bring Cholesterol Down
Forbes
Tue, 03/17/15 - 08:47 am
Amgen
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »